Shockwave Medical Stock Falls After Two Patents Ruled Invalid

Shockwave Medical Stock Falls After Two Patents Ruled Invalid

Shares of cardiovascular-health company Shockwave Medical (NASDAQ: SWAV) fell on Thursday after the Patent Trial and Appeal Board ruled that two of its patents are invalid. Previously, fellow healthcare-company Cardiovascular Systems (NASDAQ: CSII) challenged two of Shockwave Medical's patents and asked the U.S. Patent and Trademark Office to look into it. The '371 patent adds a couple of electrodes inside a balloon catheter to help break up calcification in blood vessels.